Milrinone: systemic and pulmonary hemodynamic effects in neonates after cardiac surgery.
about
Milrinone for the treatment of cardiac dysfunction in neonatesHypoplastic left heart syndrome: current considerations and expectationsPharmacotherapy for pulmonary hypertensionPart 10: Pediatric basic and advanced life support: 2010 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science With Treatment Recommendations.In vivo dilatation of the fetal and postnatal ductus arteriosus by inhibition of phosphodiesterase 3 in rats.Population pharmacokinetics and dosing regimen design of milrinone in preterm infants.Safety and efficacy of the off-label use of milrinone in pediatric patients with heart diseasesSafety of milrinone use in neonatal intensive care unitsShould dopamine be the first line inotrope in the treatment of neonatal hypotension? Review of the evidence.Pharmacological support for children with myocardial dysfunction.Clinical practice parameters for hemodynamic support of pediatric and neonatal septic shock: 2007 update from the American College of Critical Care Medicine.Age-related differences in phosphodiesterase activity and effects of chronic phosphodiesterase inhibition in idiopathic dilated cardiomyopathy.Perioperative management of patients with poorly functioning ventricles in the setting of the functionally univentricular heart.Pharmacologic strategies in neonatal pulmonary hypertension other than nitric oxide.Pediatric basic and advanced life support: 2010 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science with Treatment Recommendations.Advances in the diagnosis and management of persistent pulmonary hypertension of the newborn.Current and future therapeutic options for persistent pulmonary hypertension in the newborn.The role of milrinone in children with cardiovascular compromise: review of the literature.Haemodynamically unstable preterm infant: an unresolved management conundrum.Phosphodiesterases: emerging therapeutic targets for neonatal pulmonary hypertension.Use of milrinone to treat cardiac dysfunction in infants with pulmonary hypertension secondary to congenital diaphragmatic hernia: a review of six patients.Judgment often impossible without randomized trials. Commentary on N. Patel: use of milrinone to treat cardiac dysfunction in infants with pulmonary hypertension secondary to congenital diaphragmatic hernia: a review of six patients (Neonatology 201Challenges in understanding the impact of blood pressure management on cerebral oxygenation in the preterm brainLimitations and vulnerabilities of the neonatal cardiovascular system: considerations for anesthetic management.National prescribing trends for heart failure medications in children.Critical care for paediatric patients with heart failure.Postoperative management of heart failure in pediatric patients.Management of the Low Cardiac Output Syndrome Following Surgery for Congenital Heart Disease.Pharmacologic Approach to Heart Failure in Children.Oral Enoximone as an Alternative to Protracted Intravenous Medication in Severe Pediatric Myocardial Failure.Randomized comparative study of intravenous infusion of three different fixed doses of milrinone in pediatric patients with pulmonary hypertension undergoing open heart surgery.Milrinone is preferred to levosimendan for mesenteric perfusion in hypoxia-reoxygenated newborn piglets treated with dopamineEvaluation and optimisation of current milrinone prescribing for the treatment and prevention of low cardiac output syndrome in paediatric patients after open heart surgery using a physiology-based pharmacokinetic drug-disease model.Prostacyclin and milrinone by aerosolization improve pulmonary hemodynamics in newborn lambs with experimental pulmonary hypertension.Phase 1 study of two inodilators in neonates undergoing cardiovascular surgery.Infant pertussis deaths and the management of cardiovascular compromise.Metabolic effects of three different inotropic strategies in the newborn piglet myocardium.Pulmonary hypertension and right ventricular dysfunction in growth-restricted, extremely low birth weight neonates.Milrinone in congenital diaphragmatic hernia - a randomized pilot trial: study protocol, review of literature and survey of current practices.The Perspective of the Intensivist on Inotropes and Postoperative Care Following Pediatric Heart Surgery: An International Survey and Systematic Review of the Literature.
P2860
Q24246383-8EB22317-F762-41C3-AFF7-FA2DD3B7C995Q26821904-AD326617-3B66-4706-871C-5DE917065095Q27022763-C0B2EE1A-D382-4E09-8B9F-66F46B3F7FACQ30543305-50879BFE-FC82-4811-8C46-5823533CF692Q33228224-4225E94C-9CA3-41A5-8F12-7BAB253831F4Q33243169-21A5FE7E-3C39-4F39-9CBF-D3DD6ECCAE29Q33417974-F6A2528E-27D0-4A82-A820-C9F8070D6AC0Q33419080-5D21176F-B17C-4FE4-B494-3293D165B8C2Q34526228-74994857-B309-4EB7-80D6-8DC5B2808E53Q34534627-16485DD1-30E7-4A95-934B-49FC132262E2Q34605888-F184B3DD-3B99-440B-A724-9BCE42965BBCQ35002036-6BFEF20B-0CFD-47BB-B280-D85866239EE9Q36364102-1AD8265F-388E-4FE0-880C-9B82D270B42CQ36730928-3EF0C4BF-433C-48F0-AB95-80F73C35B107Q37200292-5B709EEB-AB16-45BC-ACFE-EBFF15C94CD0Q37510031-94233B41-C00D-440C-9996-D57DFBC3086EQ37763202-206D9597-2E22-44C5-8F59-C3C90A34A3FFQ37848243-C520FCA7-2FBC-430B-91FC-5E8A0131B4D8Q37855650-2B85E5C1-758B-480E-BF74-94A7399D6A44Q37893072-84CBC3D2-C789-462E-B5D4-8E6C35A4F688Q38019771-2B440F5A-03AE-477F-9035-DF664B3A3753Q38019776-4A630CE7-1D1A-482A-AA44-DBBF375E8065Q38069574-0F266D40-3860-4ACC-A689-7FE71FD038C8Q38170570-75BA29E5-0277-42DD-9458-ED98877B197DQ38204017-2B3CDAF0-8D93-4469-9EC8-A1F5F16341B5Q38588160-BBF75659-602F-43B1-AA1C-754262D15093Q38631238-9FF7F3A4-3EC5-422B-B79A-5DC4DE4E60A4Q38638911-FB26ACC3-7D3E-4172-B629-DF728696A267Q38798856-7F7DCA55-E9C6-41CA-9F70-1E66792B1B6DQ40625826-BB16EC27-2919-42EF-AF23-64C6CED9D088Q41178906-F49889CC-856E-4BF5-BD0B-0430AC6D02F8Q42113287-A633C49C-FDB9-4BA3-B36C-A49A987CD708Q42608257-C678A623-F012-4C55-819A-0FE6D67C702CQ42975737-32B73CE5-4B21-4E19-902D-9D8E4AE20EB4Q43798759-1F5E8C06-DADD-47B7-AA2D-58B99042B424Q44792236-418E049A-B3C5-4267-8B3A-8DCF23A37DB6Q45101499-0AB0C7F0-D6A9-4A2C-B0D6-A941D17BAD19Q46437385-D8CB47B3-C8AA-4DF2-9E58-5DFB2830B3BDQ47096506-7DD6342F-C197-47F9-A15A-E5905D3E198BQ48380637-82A4D443-5073-44DE-92CF-FE1EB103AED2
P2860
Milrinone: systemic and pulmonary hemodynamic effects in neonates after cardiac surgery.
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
1995年论文
@zh
1995年论文
@zh-cn
name
Milrinone: systemic and pulmonary hemodynamic effects in neonates after cardiac surgery.
@en
Milrinone: systemic and pulmonary hemodynamic effects in neonates after cardiac surgery.
@nl
type
label
Milrinone: systemic and pulmonary hemodynamic effects in neonates after cardiac surgery.
@en
Milrinone: systemic and pulmonary hemodynamic effects in neonates after cardiac surgery.
@nl
prefLabel
Milrinone: systemic and pulmonary hemodynamic effects in neonates after cardiac surgery.
@en
Milrinone: systemic and pulmonary hemodynamic effects in neonates after cardiac surgery.
@nl
P2093
P1476
Milrinone: systemic and pulmonary hemodynamic effects in neonates after cardiac surgery.
@en
P2093
P304
P356
10.1097/00003246-199511000-00018
P407
P577
1995-11-01T00:00:00Z